GlassScriptPhysician profile
Richard Kim Le
NPI 1851393003
$16,713.64
in general payments reported to CMS, 2019-2025
64 companies · $1,915 in 2025
The $1,915 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,088 · 2020: $3,414 · 2021: $2,296 · 2022: $2,427 · 2023: $2,333 · 2024: $2,240 · 2025: $1,915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,427 · Entertainment: $40.92 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,427.12 |
| Entertainment | $40.92 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $4,255.18 | 2019-2025 | Vemlidy, Livdelzi |
| Astrazeneca Pharmaceuticals LP | $1,787.72 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $1,235.71 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $1,164.77 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Abbvie INC. | $735.31 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $730.87 | 2019-2025 | Jardiance, Jascayd |
| Amarin Pharma, INC. | $722.76 | 2019-2022 | |
| Amgen INC. | $707.14 | 2019-2025 | Repatha, Otezla, Krystexxa |
| Bayer Healthcare Pharmaceuticals INC. | $438.86 | 2021-2025 | |
| Philips North America LLC | $387.17 | 2019-2025 | Vest Therapy Und |
| Kowa Pharmaceuticals America, INC. | $385.13 | 2019-2024 | Livalo, Seglentis |
| Abbott Laboratories | $384.26 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2, Aveir |
| Novartis Pharmaceuticals Corporation | $341.37 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $280.34 | 2020-2024 | Verquvo, Gardasil 9, Belsomra |
| Glaxosmithkline, LLC. | $278.26 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $198.16 | 2024-2025 | Rexulti |
| Sanofi-Aventis U.S. LLC | $179.41 | 2019-2025 | |
| Pfizer INC. | $177.21 | 2019-2025 | |
| Esperion Therapeutics, INC. | $167.16 | 2021-2025 | Nexletol |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $154.75 | 2019-2023 | Xifaxan |
| Lundbeck LLC | $147.07 | 2023-2025 | Rexulti |
| Tolmar, INC. | $136.72 | 2024-2025 | Jatenzo |
| Janssen Pharmaceuticals, INC | $133.77 | 2019-2022 | |
| Astellas Pharma US INC | $125.77 | 2023-2025 | Veozah, Myrbetriq |
| Corcept Therapeutics | $96.91 | 2024-2025 | Korlym |
| Exact Sciences Corporation | $89.89 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Verity Pharmaceuticals INC. | $76.30 | 2024-2025 | Tlando |
| Eisai INC. | $69.08 | 2020-2022 | |
| Allergan, INC. | $69.06 | 2020-2021 | |
| Dynavax Technologies Corporation | $63.47 | 2019-2021 | |
| Therapeuticsmd, INC. | $62.31 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $58.65 | 2019-2020 | |
| Horizon Therapeutics Plc | $57.93 | 2021-2022 | |
| Boston Scientific Corporation | $55.83 | 2022-2023 | Watchman Access System |
| Sanofi Pasteur INC. | $54.92 | 2020-2023 | |
| Currax Pharmaceuticals LLC | $52.66 | 2022-2023 | Contrave, Onzetra Xsail, Nexletol |
| Vanda Pharmaceuticals INC. | $43.60 | 2025 | Fanapt |
| Optos, INC. | $40.92 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Impulse Dynamics (USA) INC. | $39.58 | 2024 | Optimizer |
| Phadia US INC. | $34.99 | 2019-2021 | |
| Redhill Biopharma INC. | $33.82 | 2021 | |
| Xeris Pharmaceuticals, INC. | $30.16 | 2025 | Keveyis |
| Lucid Diagnostics INC. | $27.55 | 2022 | |
| Nevro Corp. | $26.02 | 2022 | |
| Ardelyx, INC. | $25.80 | 2024 | Ibsrela |
| Bioventus LLC | $24.79 | 2019 | |
| Phathom Pharmaceuticals, INC. | $24.59 | 2025 | Voquezna |
| Grifols USA, LLC | $23.45 | 2020 | |
| Intra-Sana Laboratories | $23.11 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Optinose US, INC. | $23.11 | 2025 | |
| Biotronik INC. | $22.20 | 2021 | |
| Antares Pharma, INC. | $22.12 | 2024 | Xyosted |
| Teleflex LLC | $19.23 | 2022 | |
| Axonics, INC. | $18.26 | 2023 | Axonics |
| Biomerieux INC | $18.00 | 2025 | Biofire Spotfire Control Station |
| Coloplast Corp | $17.25 | 2023 | Titan |
| Vbi Vaccine (Delaware) INC. | $15.54 | 2022 | |
| Radius Health, INC. | $15.24 | 2021 | |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Dexcom, INC. | $14.09 | 2021 | |
| Evoke Pharma, INC. | $14.01 | 2025 | |
| Itamar Medical INC | $13.50 | 2023 | Watchpatone |
| Azurity Pharmaceuticals, INC. | $13.38 | 2023 | Edarbi |
| Endo Pharmaceuticals INC. | $12.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.